The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Concurrent Session: Coping with Data Integrity & Digitalization in Supply Chain | Globalization, pandemic, and digital transformation have been the key players of the past decade within the pharma manufacturing environment, generating a complex landscape to navigate. While regulated firms are forced to rely on suppliers and outsourced processes, it is also true that digitization is never really over: to manage and meet realistic product and technology expectations, companies should leverage strong supplier knowledge, data integrity surveillance programs, and avoid bottlenecks in their decision-making processes. Emphasizing the current impact and stress on the supply chain, the presentations of this session are intended to offer a concrete holistic approach to guarantee resilience, product quality, the accelerated construction of the facilities for new therapies, and last but not least, patient safety. The speakers will provide a clear overview of the main lessons learned, new approaches for business plans, and case studies related to fast-track projects designed to provide manufacturing capacity for a growing market such as virotherapy.
Speaker(s):
Mr. Thomas
CARGANICO,
Global Marketing & Communication Director Local Equity Partner,
PQE Group
Geir Rune
Flaten,
PhD,
Director, Global Solution Consulting,
AspenTech
Emily
Heffernan,
PE,
US Director, New Process Technology,
Arcadis DPS Group
Ms. Carol
A. Houts,
VP of Quality and Regulatory,
Germfree Laboratories, Inc.